43
|
118
|
7l9aA |
Crystal structure of brdt bromodomain 2 in complex with cdd-1102 |
1
|
12
|
6ultI |
Brd2-bd2 in complex with the cyclic peptide 4.2_3 |
1
|
14
|
6ulvE |
Brd4-bd1 in complex with the cyclic peptide 4.2_1 |
36
|
108
|
6ulvA |
Brd4-bd1 in complex with the cyclic peptide 4.2_1 |
0
|
11
|
6u4aC |
Brd3-bd1 in complex with the cyclic peptide 3.1_3 |
0
|
11
|
6u61D |
Brd2-bd1 in complex with the cyclic peptide 3.1_3 |
42
|
127
|
6u72A |
Brd4-bd1 in complex with the cyclic peptide 3.1_2_ack5toa |
0
|
14
|
6u8gE |
Brd4-bd2 in complex with the cyclic peptide 3.1_2_ack7toa |
0
|
14
|
6u6lB |
Brd4-bd2 in complex with the cyclic peptide 3.1_2 |
0
|
14
|
6u74E |
Brd4-bd1 in complex with the cyclic peptide 3.1_2 |
38
|
118
|
6u61A |
Brd2-bd1 in complex with the cyclic peptide 3.1_3 |
1
|
12
|
6u8hC |
Brd2-bd1 in complex with the cyclic peptide 3.2_2 |
41
|
120
|
6u4aA |
Brd3-bd1 in complex with the cyclic peptide 3.1_3 |
0
|
17
|
6u8mC |
Brd4-bd1 in complex with the cyclic peptide 3.2_1 |
1
|
12
|
6u8iB |
Brd4-bd2 in complex with the cyclic peptide 3.2_2 |
35
|
112
|
6u6lA |
Brd4-bd2 in complex with the cyclic peptide 3.1_2 |
41
|
126
|
6ulqA |
Brd2-bd1 in complex with the cyclic peptide 4.2_3 |
33
|
110
|
6ulpA |
Brd3-bd2 in complex with the cyclic peptide 3.2_3 |
39
|
125
|
6u8mA |
Brd4-bd1 in complex with the cyclic peptide 3.2_1 |
4
|
15
|
6ulqD |
Brd2-bd1 in complex with the cyclic peptide 4.2_3 |
0
|
14
|
6u72C |
Brd4-bd1 in complex with the cyclic peptide 3.1_2_ack5toa |
39
|
126
|
6u8gA |
Brd4-bd2 in complex with the cyclic peptide 3.1_2_ack7toa |
0
|
11
|
6u6kC |
Brd4-bd1 in complex with the cyclic peptide 3.1_3 |
40
|
110
|
6u71A |
Brd2-bd2 in complex with the cyclic peptide 3.1_3 |
43
|
126
|
6u6kA |
Brd4-bd1 in complex with the cyclic peptide 3.1_3 |
43
|
128
|
6u8hA |
Brd2-bd1 in complex with the cyclic peptide 3.2_2 |
38
|
109
|
6u8iA |
Brd4-bd2 in complex with the cyclic peptide 3.2_2 |
42
|
128
|
6u74A |
Brd4-bd1 in complex with the cyclic peptide 3.1_2 |
0
|
11
|
6u71B |
Brd2-bd2 in complex with the cyclic peptide 3.1_3 |
57
|
230
|
6uycA |
Crystal structure of tead2 bound to compound 2 |
102
|
311
|
6u6wA |
Discovery and optimization of salicyclic acid-derived sulfonamide inhibitors of the wdr5:myc protein-protein interaction |
39
|
115
|
6ddjA |
Crystal structure of the human brd2 bd2 bromodimain in complex with a tetrahydroquinoline analogue |
37
|
109
|
6db0A |
N-terminal bromodomain of human brd2 with a tetrahydroquinoline analogue |
40
|
115
|
6ddiA |
Crystal structure of the human brd2 bd1 bromodomain in complex with a tetrahydroquinoline analogue |
40
|
115
|
6dbcA |
Second bromodomain of human brd2 with a tetrahydroquinoline analogue |
0
|
4
|
5h7hB |
Crystal structure of the bcl6 btb domain in complex with f1324(10-13) |
55
|
134
|
6df4A |
Taf1-bd2 in complex with cpd8 (6-(but-3-en-1-yl)-4-(3-(morpholine-4-carbonyl)phenyl)-1,6-dihydro-7h-pyrrolo[2,3-c]pyridin-7-one) |
54
|
135
|
6df7A |
Taf1-bd2 in complex with cpd27 (6-(but-3-en-1-yl)-4-(1-methyl-6-(morpholine-4-carbonyl)-1h-benzo[d]imidazol-4-yl)-1,6-dihydro-7h-pyrrolo[2,3-c]pyridin-7-one) |
42
|
126
|
5yovA |
Crystal structure of brd4-bd1 bound with hjp126 |
39
|
123
|
5youA |
Crystal structure of brd4-bd1 bound with hjp64 |
49
|
228
|
6e5gA |
Crystal structure of human tead2-yap binding domain covalently bound to an allosteric regulator |
43
|
125
|
6cj2A |
Crystal structure of the first bromodomain of human brd4 in complex with the inhibitor jwg056 |
41
|
123
|
6c3nA |
Crystal structure of bcl6 btb domain in complex with compound 7cc5 |
43
|
125
|
6cd5A |
Crystal structure of the first bromodomain of human brd4 in complex with the inhibitor xmd17-26 |
40
|
127
|
5z90A |
Brd4 bromodomain 1 with an inhibitor |
41
|
127
|
5z8gA |
Brd4 bromodomain 1 with an inhibitor |
39
|
124
|
5z5uA |
The first bromodomain of brd4 with compound bdf-2254 |
37
|
127
|
5z8rA |
Brd4 bromodomain 1 with an inhibitor |
41
|
124
|
5z5vA |
The first bromodomain of brd4 with compound bdf-1253 |
43
|
124
|
5z5tA |
The first bromodomain of brd4 with compound bdf-2141 |